Divi's Laboratories Limited (DIVISLAB.NS)
-NSE 995.00 
11.45(1.14%) 6:00AM EDT
| Prev Close: | 1,006.45 |
|---|
| Open: | 1,008.00 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 982.70 - 1,019.00 |
|---|
| 52wk Range: | 898.95 - 1,234.40 |
|---|
| Volume: | 484,881 |
|---|
| Avg Vol (3m): | 141,583 |
|---|
| Market Cap: | 132.07B |
|---|
| P/E (ttm): | 24.76 |
|---|
| EPS (ttm): | 40.19 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in INR.
Headlines
- No Headlines available for DIVISLAB.NS at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 7.18 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Divis Laboratories Limited engages in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for generics in India. It provides building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarot...
View More